Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis
Condition(s):Fibrillary GlomerulonephritisLast Updated:February 6, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Fibrillary GlomerulonephritisLast Updated:February 6, 2019Completed
Condition(s):Glomerulonephritis, MembranoproliferativeLast Updated:January 16, 2013Completed
Condition(s):Chronic Kidney Disease Stage 3B; Chronic Kidney Disease stage4; GlomerulonephritisLast Updated:April 20, 2020Unknown status
Condition(s):ADPKD; GlomerulonephritisLast Updated:June 27, 2006Completed
Condition(s):Membranous NephropathyLast Updated:May 6, 2023Recruiting
Condition(s):Renal Insufficiency, ChronicLast Updated:January 3, 2024Recruiting
Condition(s):C3G; IC-MPGN; C3 Glomerulopathy; C3 Glomerulonephritis; Complement 3 Glomerulopathy; Complement 3 Glomerulopathy (C3G); Complement 3 Glomerulonephritis; Dense Deposit Disease; DDD; Membranoproliferative Glomerulonephritis; Membranoproliferative Glomerulonephritis (MPGN); Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)Last Updated:March 12, 2024Active, not recruiting
Condition(s):C3G; IC-MPGN; C3 Glomerulopathy; C3 Glomerulonephritis; Complement 3 Glomerulopathy; Complement 3 Glomerulopathy (C3G); Complement 3 Glomerulonephritis; Dense Deposit Disease; DDD; Membranoproliferative Glomerulonephritis; Membranoproliferative Glomerulonephritis (MPGN); Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)Last Updated:March 12, 2024Active, not recruiting
Condition(s):C3 Glomerulonephritis; C3 Glomerulopathy; Immune Complex Membranoproliferative Glomerulonephritis; IC-MPGN; Dense Deposit DiseaseLast Updated:November 26, 2021Completed
Condition(s):Chronic Glomerulonephritis; Diabetic NephropathyLast Updated:September 29, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.